Becton, Dickinson and Company (LON:0R19)

Market Cap	39.13B -31.1%
Revenue (ttm)	16.29B +6.2%
Net Income	1.31B +1.7%
EPS	4.55 +3.1%
Shares Out	n/a
PE Ratio	29.97
Forward PE	14.66
Dividend	3.13 (1.70%)
Ex-Dividend Date	Dec 8, 2025

Volume	1,898
Average Volume	1,199
Open	183.00
Previous Close	182.84
Day's Range	180.63 - 185.34
52-Week Range	162.29 - 234.99
Beta	0.29
RSI	41.80
Earnings Date	Feb 9, 2026

About LON:0R19

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1897
• Employees: 72,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R19

Financial Performance

In fiscal year 2025, LON:0R19's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD